- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05513755
Cardioneuroablation in Reflex Syncope (CARDIOSYRE Trial) (CARDIOSYE)
Randomized Trial of Cardioneuroablation in Reflex Syncope Treatment (CARDIOSYE Trial)
Background: Reflex syncope is a disease of benign etiology but in severe cases it can be disabling and it carries a risk of severe trauma. Today, there is no proven etiological treatment and only palliative treatments are used, namely a change in hygienic and dietary habits, certain drugs or, in the most severe cases, the implantation of a pacemaker. Cardioneuroablation is a novel technique that acts by ablating the parasympathetic ganglia located on the external walls of the atria. Several prospective series with promising results have been published, but there are no randomized studies that have validated its efficacy compared to conventional treatment.
Methods: The CARDIOSYRE study is a multicenter, randomized, single-blinded study of patients with reflex syncope. The aim is to recruit, between June 2022 and June 2025, 92 patients with reflex cardioinhibitory syncope in 15 centers and randomize them (1:1 ratio) to two treatment groups: 1) cardioneuroablation intervention; 2) conventional treatment (control group). The primary end-point will be the time to the first syncope and the secondary end-point will be the total incidence of syncope after one year of follow-up. At least 20 recurrences of syncope are expected during a 1-year follow-up. A relative risk of 0.3 and a statistical power of 80% are assumed. The follow-up will be carried out at 3, 6 and 12 months. Cox models will be used to estimate adjusted Hazard ratios.
Study Overview
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Maria T Barrio-Lopez, MD, PhD
- Phone Number: 2710 +34917089900
- Email: terebarriol@gmail.com
Study Contact Backup
- Name: Jesus Almendral, MD, PhD, FESC
- Email: almendraljesus@gmail.com
Study Locations
-
-
-
Madrid, Spain, 28660
- Recruiting
- Teresa Barrio López
-
Contact:
- Jesus Almendral, MD, PhD, FESC
- Email: almendraljesus@gmail.com
-
Contact:
- María T Barrio Lopez, MD, PhD
- Phone Number: 2710 034917089900
- Email: terebarriol@gmail.com
-
Principal Investigator:
- Jesus M Almendral, MD, PhD, FESCMPH
-
Principal Investigator:
- Angel Moya Mitjans, MD, PhD
-
Principal Investigator:
- Jesus Martinez Alday, MD, PhD
-
Sub-Investigator:
- Carlos A Alvarez, MD, PhD
-
Sub-Investigator:
- Oscar Alcalde, MD, PhD
-
Sub-Investigator:
- Nuria Basterra, MD, PhD
-
Sub-Investigator:
- Jose L Ibañez, MD, PhD
-
Sub-Investigator:
- Alicia Ibañez, MD, PhD
-
Sub-Investigator:
- Rosa Macias, MD, PhD
-
Sub-Investigator:
- Miguel Alvarez, MD, PhD
-
Sub-Investigator:
- Jordi Pérez, MD, PhD
-
Sub-Investigator:
- Jaume Francisco, MD, PhD
-
Sub-Investigator:
- Felipe Rodriguez Entem, MD, PhD
-
Sub-Investigator:
- Victor Exposito, MD, PhD
-
Sub-Investigator:
- Pablo E Garcia Granja, MD, PhD
-
Sub-Investigator:
- Cristina Aguilera, MD, PhD
-
Sub-Investigator:
- Eusebio Garcia-Izquierdo, MD, PhD
-
Sub-Investigator:
- Sebastian Giacoman, MD, PhD
-
Sub-Investigator:
- Jose M Lozano, MD, PhD
-
Sub-Investigator:
- Javier Fernadez-Portales, MD, PhD
-
Sub-Investigator:
- Sofia Calero, MD, PhD
-
Sub-Investigator:
- Victor Hidalgo, MD, PhD
-
Sub-Investigator:
- Larraitz Gaztañaga, MD, PhD
-
Sub-Investigator:
- Eduardo Franco, MD, PhD
-
Sub-Investigator:
- Juan M Duran, MD, PhD
-
Sub-Investigator:
- Andreu Porta-Sanchez, MD, PhD
-
Sub-Investigator:
- Ivo Roca, MD, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with reflex syncope (two or more episodes in the last year) and cardioinhibitory response (documentation of asystole >3 seconds coinciding with syncope or >6 seconds outside of syncope or cardioinhibitory response on the tilt test) defined such as heart rate < 40 bpm for at least 10 seconds or asystolic pause > 3 seconds
Exclusion Criteria:
- Patients under 18 years
- Any pathology or medical condition that limits survival to less than one year;
- Illegal drug use, chronic alcoholism, or total alcohol use >80 g/d
- Participation in a clinical trial conducted with drugs or use of a drug in an experimental state during the year prior to inclusion
- Patients institutionalized for chronic treatment, with a lack of autonomy and with the impossibility of carrying out clinical follow-ups
- Patients with pacemakers, patients with intrinsic disease of the cardiac conduction system or bundle branch block
- Patients with structural heart disease.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Cardioneuroablation
|
Endocardical radiofrequency ablation of vagal ganglia located close to pulmonary veins antra and interatrial septum.
|
No Intervention: Conventional treatment (counter-pressurre maneuver, drugs or pacemaker)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
time to the first syncope
Time Frame: 12 months
|
time from the randomization to the first syncope
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
number of syncopes during the follow-up period
Time Frame: 12 months
|
number of syncopes during the follow-up period
|
12 months
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Cardioneuroablation in Syncope
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Reflex Syncope
-
Gruppo Italiano Multidisciplinare per lo Studio...Completed
-
Centre of Postgraduate Medical EducationRecruiting
-
Gruppo Italiano Multidisciplinare per lo Studio...Completed
-
Institut d'Investigació Biomèdica de BellvitgeRecruiting
-
Biotronik SE & Co. KGCompletedSyncopeFrance, Spain, Italy, Netherlands, Canada, Portugal
-
Boston Scientific CorporationCompletedOrthostatic Hypotension | Reflex SyncopeUnited States
-
Tel-Aviv Sourasky Medical CenterUnknownVenoarteriolar Reflex
-
David B. De LurgioBiosense Webster, Inc.CompletedNeurocardiogenic Syncope | Vasovagal SyncopeUnited States
-
TC Erciyes UniversityCompletedRadiculopathy | Hoffman's ReflexTurkey
-
University of CalgaryNot yet recruitingSyncope | Vasovagal Syncope (VVS)Canada
Clinical Trials on cardioneuroablation
-
University Hospital, BordeauxNot yet recruitingBradycardia | Heart Arrest | Syncope, VasovagalFrance
-
Centre of Postgraduate Medical EducationCompleted
-
St. Joseph's Centre, PolandCompletedAtrial Fibrillation ParoxysmalPoland
-
David B. De LurgioBiosense Webster, Inc.CompletedNeurocardiogenic Syncope | Vasovagal SyncopeUnited States
-
China National Center for Cardiovascular DiseasesChinese Academy of Medical Sciences, Fuwai Hospital; Shanghai Jiaotong University... and other collaboratorsUnknownSick Sinus Syndrome | Permanent Pacemaker Implantation | Cardioneuroablation | Ganglionated PlexusChina
-
St. Joseph's Centre, PolandNot yet recruitingAtrial Fibrillation Paroxysmal
-
China National Center for Cardiovascular DiseasesCompleted
-
American Heart of PolandRecruitingAtrioventricular BlockPoland
-
Hospital Clinico Universitario de SantiagoSpanish Society of Cardiology; Hospital Universitario Lucus AugustiRecruitingSick Sinus Syndrome | Sinus Node DysfunctionSpain
-
4th Military Clinical Hospital with Polyclinic,...Recruiting